Unresectable Malignant Solid Neoplasm Recruiting Phase 2 Trials for Ipatasertib (DB11743)

Indication	Status	Phase
DBCOND0110416 (Unresectable Malignant Solid Neoplasm)	Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT05554380	Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial	Treatment	Ipatasertib (DB11743) Paclitaxel (DB01229)
NCT05564377	Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial	Screening	Alpelisib (DB12015) Binimetinib (DB11967) Fluorouracil (DB00544) Fulvestrant (DB00947) Hydrogen (DB15127) Ipatasertib (DB11743) Leucovorin (DB00650) Neratinib (DB11828) Nilotinib (DB04868) Olaparib (DB09074) Oxaliplatin (DB00526) Paclitaxel (DB01229) Palbociclib (DB09073) Panitumumab (DB01269) Selumetinib (DB11689) Sotorasib (DB15569) Sulfate ion (DB14546)